English
简体中文
Total: £ 56.28
Published Date: 2024-11-25 | Pages: 127 | Tables: 240 | Pharma & Healthcare
The global market for Pruritus Type Skin Diseases Medicine was estimated to be worth US$ 5100 million in 2023 and is forecast to a readjusted size of US$ 6771.8 million by 2030 with a CAGR of 4.5% during the forecast period 2024-2030
North American market for Pruritus Type Skin Diseases Medicine was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Pruritus Type Skin Diseases Medicine was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Pruritus Type Skin Diseases Medicine was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Pruritus Type Skin Diseases Medicine include AbbVie, Inc. (Allergan plc), Albireo Pharma, Inc., Astellas Pharma Inc., Cipla Limited, Eli Lilly and Company, GSK plc, Merck & Co., Inc., Pfizer, Inc. and Teva Pharmaceutical Industries Ltd., etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pruritus Type Skin Diseases Medicine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Pruritus Type Skin Diseases Medicine by region & country, by Type, and by Application.
The Pruritus Type Skin Diseases Medicine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pruritus Type Skin Diseases Medicine.
Market Segmentation
By Company
AbbVie, Inc. (Allergan plc)
Albireo Pharma, Inc.
Astellas Pharma Inc.
Cipla Limited
Eli Lilly and Company
GSK plc
Merck & Co., Inc.
Pfizer, Inc.
Teva Pharmaceutical Industries Ltd.
Viatris Inc. (Mylan N.V.)
Segment by Type:
External Medication
Oral Medication
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Pruritus Type Skin Diseases Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Pruritus Type Skin Diseases Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Pruritus Type Skin Diseases Medicine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Pruritus Type Skin Diseases Medicine Product Introduction
1.2 Global Pruritus Type Skin Diseases Medicine Market Size Forecast
1.2.1 Global Pruritus Type Skin Diseases Medicine Sales Value (2019-2030)
1.2.2 Global Pruritus Type Skin Diseases Medicine Sales Volume (2019-2030)
1.2.3 Global Pruritus Type Skin Diseases Medicine Sales Price (2019-2030)
1.3 Pruritus Type Skin Diseases Medicine Market Trends & Drivers
1.3.1 Pruritus Type Skin Diseases Medicine Industry Trends
1.3.2 Pruritus Type Skin Diseases Medicine Market Drivers & Opportunity
1.3.3 Pruritus Type Skin Diseases Medicine Market Challenges
1.3.4 Pruritus Type Skin Diseases Medicine Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Pruritus Type Skin Diseases Medicine Players Revenue Ranking (2023)
2.2 Global Pruritus Type Skin Diseases Medicine Revenue by Company (2019-2024)
2.3 Global Pruritus Type Skin Diseases Medicine Players Sales Volume Ranking (2023)
2.4 Global Pruritus Type Skin Diseases Medicine Sales Volume by Company Players (2019-2024)
2.5 Global Pruritus Type Skin Diseases Medicine Average Price by Company (2019-2024)
2.6 Key Manufacturers Pruritus Type Skin Diseases Medicine Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Pruritus Type Skin Diseases Medicine Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Pruritus Type Skin Diseases Medicine
2.9 Pruritus Type Skin Diseases Medicine Market Competitive Analysis
2.9.1 Pruritus Type Skin Diseases Medicine Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Pruritus Type Skin Diseases Medicine Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pruritus Type Skin Diseases Medicine as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 External Medication
3.1.2 Oral Medication
3.2 Global Pruritus Type Skin Diseases Medicine Sales Value by Type
3.2.1 Global Pruritus Type Skin Diseases Medicine Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Pruritus Type Skin Diseases Medicine Sales Value, by Type (2019-2030)
3.2.3 Global Pruritus Type Skin Diseases Medicine Sales Value, by Type (%) (2019-2030)
3.3 Global Pruritus Type Skin Diseases Medicine Sales Volume by Type
3.3.1 Global Pruritus Type Skin Diseases Medicine Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Pruritus Type Skin Diseases Medicine Sales Volume, by Type (2019-2030)
3.3.3 Global Pruritus Type Skin Diseases Medicine Sales Volume, by Type (%) (2019-2030)
3.4 Global Pruritus Type Skin Diseases Medicine Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital Pharmacies
4.1.2 Retail Pharmacies
4.1.3 Online Pharmacies
4.2 Global Pruritus Type Skin Diseases Medicine Sales Value by Application
4.2.1 Global Pruritus Type Skin Diseases Medicine Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Pruritus Type Skin Diseases Medicine Sales Value, by Application (2019-2030)
4.2.3 Global Pruritus Type Skin Diseases Medicine Sales Value, by Application (%) (2019-2030)
4.3 Global Pruritus Type Skin Diseases Medicine Sales Volume by Application
4.3.1 Global Pruritus Type Skin Diseases Medicine Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Pruritus Type Skin Diseases Medicine Sales Volume, by Application (2019-2030)
4.3.3 Global Pruritus Type Skin Diseases Medicine Sales Volume, by Application (%) (2019-2030)
4.4 Global Pruritus Type Skin Diseases Medicine Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Pruritus Type Skin Diseases Medicine Sales Value by Region
5.1.1 Global Pruritus Type Skin Diseases Medicine Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Pruritus Type Skin Diseases Medicine Sales Value by Region (2019-2024)
5.1.3 Global Pruritus Type Skin Diseases Medicine Sales Value by Region (2025-2030)
5.1.4 Global Pruritus Type Skin Diseases Medicine Sales Value by Region (%), (2019-2030)
5.2 Global Pruritus Type Skin Diseases Medicine Sales Volume by Region
5.2.1 Global Pruritus Type Skin Diseases Medicine Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Pruritus Type Skin Diseases Medicine Sales Volume by Region (2019-2024)
5.2.3 Global Pruritus Type Skin Diseases Medicine Sales Volume by Region (2025-2030)
5.2.4 Global Pruritus Type Skin Diseases Medicine Sales Volume by Region (%), (2019-2030)
5.3 Global Pruritus Type Skin Diseases Medicine Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Pruritus Type Skin Diseases Medicine Sales Value, 2019-2030
5.4.2 North America Pruritus Type Skin Diseases Medicine Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Pruritus Type Skin Diseases Medicine Sales Value, 2019-2030
5.5.2 Europe Pruritus Type Skin Diseases Medicine Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Pruritus Type Skin Diseases Medicine Sales Value, 2019-2030
5.6.2 Asia Pacific Pruritus Type Skin Diseases Medicine Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Pruritus Type Skin Diseases Medicine Sales Value, 2019-2030
5.7.2 South America Pruritus Type Skin Diseases Medicine Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Pruritus Type Skin Diseases Medicine Sales Value, 2019-2030
5.8.2 Middle East & Africa Pruritus Type Skin Diseases Medicine Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Pruritus Type Skin Diseases Medicine Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Pruritus Type Skin Diseases Medicine Sales Value
6.2.1 Key Countries/Regions Pruritus Type Skin Diseases Medicine Sales Value, 2019-2030
6.2.2 Key Countries/Regions Pruritus Type Skin Diseases Medicine Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Pruritus Type Skin Diseases Medicine Sales Value, 2019-2030
6.3.2 United States Pruritus Type Skin Diseases Medicine Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Pruritus Type Skin Diseases Medicine Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Pruritus Type Skin Diseases Medicine Sales Value, 2019-2030
6.4.2 Europe Pruritus Type Skin Diseases Medicine Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Pruritus Type Skin Diseases Medicine Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Pruritus Type Skin Diseases Medicine Sales Value, 2019-2030
6.5.2 China Pruritus Type Skin Diseases Medicine Sales Value by Type (%), 2023 VS 2030
6.5.3 China Pruritus Type Skin Diseases Medicine Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Pruritus Type Skin Diseases Medicine Sales Value, 2019-2030
6.6.2 Japan Pruritus Type Skin Diseases Medicine Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Pruritus Type Skin Diseases Medicine Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Pruritus Type Skin Diseases Medicine Sales Value, 2019-2030
6.7.2 South Korea Pruritus Type Skin Diseases Medicine Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Pruritus Type Skin Diseases Medicine Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Pruritus Type Skin Diseases Medicine Sales Value, 2019-2030
6.8.2 Southeast Asia Pruritus Type Skin Diseases Medicine Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Pruritus Type Skin Diseases Medicine Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Pruritus Type Skin Diseases Medicine Sales Value, 2019-2030
6.9.2 India Pruritus Type Skin Diseases Medicine Sales Value by Type (%), 2023 VS 2030
6.9.3 India Pruritus Type Skin Diseases Medicine Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 AbbVie, Inc. (Allergan plc)
7.1.1 AbbVie, Inc. (Allergan plc) Company Information
7.1.2 AbbVie, Inc. (Allergan plc) Introduction and Business Overview
7.1.3 AbbVie, Inc. (Allergan plc) Pruritus Type Skin Diseases Medicine Sales, Revenue and Gross Margin (2019-2024)
7.1.4 AbbVie, Inc. (Allergan plc) Pruritus Type Skin Diseases Medicine Product Offerings
7.1.5 AbbVie, Inc. (Allergan plc) Recent Development
7.2 Albireo Pharma, Inc.
7.2.1 Albireo Pharma, Inc. Company Information
7.2.2 Albireo Pharma, Inc. Introduction and Business Overview
7.2.3 Albireo Pharma, Inc. Pruritus Type Skin Diseases Medicine Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Albireo Pharma, Inc. Pruritus Type Skin Diseases Medicine Product Offerings
7.2.5 Albireo Pharma, Inc. Recent Development
7.3 Astellas Pharma Inc.
7.3.1 Astellas Pharma Inc. Company Information
7.3.2 Astellas Pharma Inc. Introduction and Business Overview
7.3.3 Astellas Pharma Inc. Pruritus Type Skin Diseases Medicine Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Astellas Pharma Inc. Pruritus Type Skin Diseases Medicine Product Offerings
7.3.5 Astellas Pharma Inc. Recent Development
7.4 Cipla Limited
7.4.1 Cipla Limited Company Information
7.4.2 Cipla Limited Introduction and Business Overview
7.4.3 Cipla Limited Pruritus Type Skin Diseases Medicine Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Cipla Limited Pruritus Type Skin Diseases Medicine Product Offerings
7.4.5 Cipla Limited Recent Development
7.5 Eli Lilly and Company
7.5.1 Eli Lilly and Company Company Information
7.5.2 Eli Lilly and Company Introduction and Business Overview
7.5.3 Eli Lilly and Company Pruritus Type Skin Diseases Medicine Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Eli Lilly and Company Pruritus Type Skin Diseases Medicine Product Offerings
7.5.5 Eli Lilly and Company Recent Development
7.6 GSK plc
7.6.1 GSK plc Company Information
7.6.2 GSK plc Introduction and Business Overview
7.6.3 GSK plc Pruritus Type Skin Diseases Medicine Sales, Revenue and Gross Margin (2019-2024)
7.6.4 GSK plc Pruritus Type Skin Diseases Medicine Product Offerings
7.6.5 GSK plc Recent Development
7.7 Merck & Co., Inc.
7.7.1 Merck & Co., Inc. Company Information
7.7.2 Merck & Co., Inc. Introduction and Business Overview
7.7.3 Merck & Co., Inc. Pruritus Type Skin Diseases Medicine Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Merck & Co., Inc. Pruritus Type Skin Diseases Medicine Product Offerings
7.7.5 Merck & Co., Inc. Recent Development
7.8 Pfizer, Inc.
7.8.1 Pfizer, Inc. Company Information
7.8.2 Pfizer, Inc. Introduction and Business Overview
7.8.3 Pfizer, Inc. Pruritus Type Skin Diseases Medicine Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Pfizer, Inc. Pruritus Type Skin Diseases Medicine Product Offerings
7.8.5 Pfizer, Inc. Recent Development
7.9 Teva Pharmaceutical Industries Ltd.
7.9.1 Teva Pharmaceutical Industries Ltd. Company Information
7.9.2 Teva Pharmaceutical Industries Ltd. Introduction and Business Overview
7.9.3 Teva Pharmaceutical Industries Ltd. Pruritus Type Skin Diseases Medicine Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Teva Pharmaceutical Industries Ltd. Pruritus Type Skin Diseases Medicine Product Offerings
7.9.5 Teva Pharmaceutical Industries Ltd. Recent Development
7.10 Viatris Inc. (Mylan N.V.)
7.10.1 Viatris Inc. (Mylan N.V.) Company Information
7.10.2 Viatris Inc. (Mylan N.V.) Introduction and Business Overview
7.10.3 Viatris Inc. (Mylan N.V.) Pruritus Type Skin Diseases Medicine Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Viatris Inc. (Mylan N.V.) Pruritus Type Skin Diseases Medicine Product Offerings
7.10.5 Viatris Inc. (Mylan N.V.) Recent Development
8 Industry Chain Analysis
8.1 Pruritus Type Skin Diseases Medicine Industrial Chain
8.2 Pruritus Type Skin Diseases Medicine Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Pruritus Type Skin Diseases Medicine Sales Model
8.5.2 Sales Channel
8.5.3 Pruritus Type Skin Diseases Medicine Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Pruritus Type Skin Diseases Medicine Market Trends
Table 2. Pruritus Type Skin Diseases Medicine Market Drivers & Opportunity
Table 3. Pruritus Type Skin Diseases Medicine Market Challenges
Table 4. Pruritus Type Skin Diseases Medicine Market Restraints
Table 5. Global Pruritus Type Skin Diseases Medicine Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Pruritus Type Skin Diseases Medicine Revenue Market Share by Company (2019-2024)
Table 7. Global Pruritus Type Skin Diseases Medicine Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Pruritus Type Skin Diseases Medicine Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Pruritus Type Skin Diseases Medicine Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Pruritus Type Skin Diseases Medicine Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Pruritus Type Skin Diseases Medicine Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Pruritus Type Skin Diseases Medicine
Table 13. Global Pruritus Type Skin Diseases Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pruritus Type Skin Diseases Medicine as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Pruritus Type Skin Diseases Medicine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Pruritus Type Skin Diseases Medicine Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Pruritus Type Skin Diseases Medicine Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Pruritus Type Skin Diseases Medicine Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Pruritus Type Skin Diseases Medicine Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Pruritus Type Skin Diseases Medicine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Pruritus Type Skin Diseases Medicine Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Pruritus Type Skin Diseases Medicine Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Pruritus Type Skin Diseases Medicine Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Pruritus Type Skin Diseases Medicine Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Pruritus Type Skin Diseases Medicine Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Pruritus Type Skin Diseases Medicine Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Pruritus Type Skin Diseases Medicine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Pruritus Type Skin Diseases Medicine Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Pruritus Type Skin Diseases Medicine Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Pruritus Type Skin Diseases Medicine Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Pruritus Type Skin Diseases Medicine Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Pruritus Type Skin Diseases Medicine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Pruritus Type Skin Diseases Medicine Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Pruritus Type Skin Diseases Medicine Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Pruritus Type Skin Diseases Medicine Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Pruritus Type Skin Diseases Medicine Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Pruritus Type Skin Diseases Medicine Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Pruritus Type Skin Diseases Medicine Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Pruritus Type Skin Diseases Medicine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Pruritus Type Skin Diseases Medicine Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Pruritus Type Skin Diseases Medicine Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Pruritus Type Skin Diseases Medicine Sales Value by Region (2019-2024) & (%)
Table 44. Global Pruritus Type Skin Diseases Medicine Sales Value by Region (2025-2030) & (%)
Table 45. Global Pruritus Type Skin Diseases Medicine Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Pruritus Type Skin Diseases Medicine Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Pruritus Type Skin Diseases Medicine Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Pruritus Type Skin Diseases Medicine Sales Volume by Region (2019-2024) & (%)
Table 49. Global Pruritus Type Skin Diseases Medicine Sales Volume by Region (2025-2030) & (%)
Table 50. Global Pruritus Type Skin Diseases Medicine Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Pruritus Type Skin Diseases Medicine Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Pruritus Type Skin Diseases Medicine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Pruritus Type Skin Diseases Medicine Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Pruritus Type Skin Diseases Medicine Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Pruritus Type Skin Diseases Medicine Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Pruritus Type Skin Diseases Medicine Sales Volume, (2025-2030) & (K Units)
Table 57. AbbVie, Inc. (Allergan plc) Company Information
Table 58. AbbVie, Inc. (Allergan plc) Introduction and Business Overview
Table 59. AbbVie, Inc. (Allergan plc) Pruritus Type Skin Diseases Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. AbbVie, Inc. (Allergan plc) Pruritus Type Skin Diseases Medicine Product Offerings
Table 61. AbbVie, Inc. (Allergan plc) Recent Development
Table 62. Albireo Pharma, Inc. Company Information
Table 63. Albireo Pharma, Inc. Introduction and Business Overview
Table 64. Albireo Pharma, Inc. Pruritus Type Skin Diseases Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Albireo Pharma, Inc. Pruritus Type Skin Diseases Medicine Product Offerings
Table 66. Albireo Pharma, Inc. Recent Development
Table 67. Astellas Pharma Inc. Company Information
Table 68. Astellas Pharma Inc. Introduction and Business Overview
Table 69. Astellas Pharma Inc. Pruritus Type Skin Diseases Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Astellas Pharma Inc. Pruritus Type Skin Diseases Medicine Product Offerings
Table 71. Astellas Pharma Inc. Recent Development
Table 72. Cipla Limited Company Information
Table 73. Cipla Limited Introduction and Business Overview
Table 74. Cipla Limited Pruritus Type Skin Diseases Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Cipla Limited Pruritus Type Skin Diseases Medicine Product Offerings
Table 76. Cipla Limited Recent Development
Table 77. Eli Lilly and Company Company Information
Table 78. Eli Lilly and Company Introduction and Business Overview
Table 79. Eli Lilly and Company Pruritus Type Skin Diseases Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Eli Lilly and Company Pruritus Type Skin Diseases Medicine Product Offerings
Table 81. Eli Lilly and Company Recent Development
Table 82. GSK plc Company Information
Table 83. GSK plc Introduction and Business Overview
Table 84. GSK plc Pruritus Type Skin Diseases Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. GSK plc Pruritus Type Skin Diseases Medicine Product Offerings
Table 86. GSK plc Recent Development
Table 87. Merck & Co., Inc. Company Information
Table 88. Merck & Co., Inc. Introduction and Business Overview
Table 89. Merck & Co., Inc. Pruritus Type Skin Diseases Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Merck & Co., Inc. Pruritus Type Skin Diseases Medicine Product Offerings
Table 91. Merck & Co., Inc. Recent Development
Table 92. Pfizer, Inc. Company Information
Table 93. Pfizer, Inc. Introduction and Business Overview
Table 94. Pfizer, Inc. Pruritus Type Skin Diseases Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Pfizer, Inc. Pruritus Type Skin Diseases Medicine Product Offerings
Table 96. Pfizer, Inc. Recent Development
Table 97. Teva Pharmaceutical Industries Ltd. Company Information
Table 98. Teva Pharmaceutical Industries Ltd. Introduction and Business Overview
Table 99. Teva Pharmaceutical Industries Ltd. Pruritus Type Skin Diseases Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Teva Pharmaceutical Industries Ltd. Pruritus Type Skin Diseases Medicine Product Offerings
Table 101. Teva Pharmaceutical Industries Ltd. Recent Development
Table 102. Viatris Inc. (Mylan N.V.) Company Information
Table 103. Viatris Inc. (Mylan N.V.) Introduction and Business Overview
Table 104. Viatris Inc. (Mylan N.V.) Pruritus Type Skin Diseases Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Viatris Inc. (Mylan N.V.) Pruritus Type Skin Diseases Medicine Product Offerings
Table 106. Viatris Inc. (Mylan N.V.) Recent Development
Table 107. Key Raw Materials Lists
Table 108. Raw Materials Key Suppliers Lists
Table 109. Pruritus Type Skin Diseases Medicine Downstream Customers
Table 110. Pruritus Type Skin Diseases Medicine Distributors List
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Pruritus Type Skin Diseases Medicine Product Picture
Figure 2. Global Pruritus Type Skin Diseases Medicine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Pruritus Type Skin Diseases Medicine Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Pruritus Type Skin Diseases Medicine Sales Volume (2019-2030) & (K Units)
Figure 5. Global Pruritus Type Skin Diseases Medicine Sales Price (2019-2030) & (US$/Unit)
Figure 6. Pruritus Type Skin Diseases Medicine Report Years Considered
Figure 7. Global Pruritus Type Skin Diseases Medicine Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Pruritus Type Skin Diseases Medicine Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Pruritus Type Skin Diseases Medicine Revenue in 2023
Figure 10. Pruritus Type Skin Diseases Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. External Medication Picture
Figure 12. Oral Medication Picture
Figure 13. Global Pruritus Type Skin Diseases Medicine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Pruritus Type Skin Diseases Medicine Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Pruritus Type Skin Diseases Medicine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 16. Global Pruritus Type Skin Diseases Medicine Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Pruritus Type Skin Diseases Medicine Price by Type (2019-2030) & (US$/Unit)
Figure 18. Product Picture of Hospital Pharmacies
Figure 19. Product Picture of Retail Pharmacies
Figure 20. Product Picture of Online Pharmacies
Figure 21. Global Pruritus Type Skin Diseases Medicine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Pruritus Type Skin Diseases Medicine Sales Value Market Share by Application, 2023 & 2030
Figure 23. Global Pruritus Type Skin Diseases Medicine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 24. Global Pruritus Type Skin Diseases Medicine Sales Volume Market Share by Application, 2023 & 2030
Figure 25. Global Pruritus Type Skin Diseases Medicine Price by Application (2019-2030) & (US$/Unit)
Figure 26. North America Pruritus Type Skin Diseases Medicine Sales Value (2019-2030) & (US$ Million)
Figure 27. North America Pruritus Type Skin Diseases Medicine Sales Value by Country (%), 2023 VS 2030
Figure 28. Europe Pruritus Type Skin Diseases Medicine Sales Value (2019-2030) & (US$ Million)
Figure 29. Europe Pruritus Type Skin Diseases Medicine Sales Value by Country (%), 2023 VS 2030
Figure 30. Asia Pacific Pruritus Type Skin Diseases Medicine Sales Value (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Pruritus Type Skin Diseases Medicine Sales Value by Country (%), 2023 VS 2030
Figure 32. South America Pruritus Type Skin Diseases Medicine Sales Value (2019-2030) & (US$ Million)
Figure 33. South America Pruritus Type Skin Diseases Medicine Sales Value by Country (%), 2023 VS 2030
Figure 34. Middle East & Africa Pruritus Type Skin Diseases Medicine Sales Value (2019-2030) & (US$ Million)
Figure 35. Middle East & Africa Pruritus Type Skin Diseases Medicine Sales Value by Country (%), 2023 VS 2030
Figure 36. Key Countries/Regions Pruritus Type Skin Diseases Medicine Sales Value (%), (2019-2030)
Figure 37. Key Countries/Regions Pruritus Type Skin Diseases Medicine Sales Volume (%), (2019-2030)
Figure 38. United States Pruritus Type Skin Diseases Medicine Sales Value, (2019-2030) & (US$ Million)
Figure 39. United States Pruritus Type Skin Diseases Medicine Sales Value by Type (%), 2023 VS 2030
Figure 40. United States Pruritus Type Skin Diseases Medicine Sales Value by Application (%), 2023 VS 2030
Figure 41. Europe Pruritus Type Skin Diseases Medicine Sales Value, (2019-2030) & (US$ Million)
Figure 42. Europe Pruritus Type Skin Diseases Medicine Sales Value by Type (%), 2023 VS 2030
Figure 43. Europe Pruritus Type Skin Diseases Medicine Sales Value by Application (%), 2023 VS 2030
Figure 44. China Pruritus Type Skin Diseases Medicine Sales Value, (2019-2030) & (US$ Million)
Figure 45. China Pruritus Type Skin Diseases Medicine Sales Value by Type (%), 2023 VS 2030
Figure 46. China Pruritus Type Skin Diseases Medicine Sales Value by Application (%), 2023 VS 2030
Figure 47. Japan Pruritus Type Skin Diseases Medicine Sales Value, (2019-2030) & (US$ Million)
Figure 48. Japan Pruritus Type Skin Diseases Medicine Sales Value by Type (%), 2023 VS 2030
Figure 49. Japan Pruritus Type Skin Diseases Medicine Sales Value by Application (%), 2023 VS 2030
Figure 50. South Korea Pruritus Type Skin Diseases Medicine Sales Value, (2019-2030) & (US$ Million)
Figure 51. South Korea Pruritus Type Skin Diseases Medicine Sales Value by Type (%), 2023 VS 2030
Figure 52. South Korea Pruritus Type Skin Diseases Medicine Sales Value by Application (%), 2023 VS 2030
Figure 53. Southeast Asia Pruritus Type Skin Diseases Medicine Sales Value, (2019-2030) & (US$ Million)
Figure 54. Southeast Asia Pruritus Type Skin Diseases Medicine Sales Value by Type (%), 2023 VS 2030
Figure 55. Southeast Asia Pruritus Type Skin Diseases Medicine Sales Value by Application (%), 2023 VS 2030
Figure 56. India Pruritus Type Skin Diseases Medicine Sales Value, (2019-2030) & (US$ Million)
Figure 57. India Pruritus Type Skin Diseases Medicine Sales Value by Type (%), 2023 VS 2030
Figure 58. India Pruritus Type Skin Diseases Medicine Sales Value by Application (%), 2023 VS 2030
Figure 59. Pruritus Type Skin Diseases Medicine Industrial Chain
Figure 60. Pruritus Type Skin Diseases Medicine Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
